Exact Sciences Corporation (EXAS)
NASDAQ: EXAS · IEX Real-Time Price · USD
46.81
-0.75 (-1.58%)
At close: Jul 19, 2024, 4:00 PM
46.88
+0.07 (0.15%)
Pre-market: Jul 22, 2024, 4:06 AM EDT
Exact Sciences Employees
Exact Sciences had 6,600 employees as of December 31, 2023. The number of employees increased by 200 or 3.13% compared to the previous year.
Employees
6,600
Change (1Y)
200
Growth (1Y)
3.13%
Revenue / Employee
$384,067
Profits / Employee
-$36,398
Market Cap
8.64B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6,600 | 200 | 3.13% |
Dec 31, 2022 | 6,400 | -100 | -1.54% |
Dec 31, 2021 | 6,500 | 1,500 | 30.00% |
Dec 31, 2020 | 5,000 | 890 | 21.65% |
Dec 31, 2019 | 4,110 | 2,133 | 107.89% |
Dec 31, 2018 | 1,977 | 709 | 55.91% |
Dec 31, 2017 | 1,268 | 532 | 72.28% |
Dec 31, 2016 | 736 | 59 | 8.71% |
Dec 31, 2015 | 677 | 441 | 186.86% |
Dec 31, 2014 | 236 | 134 | 131.37% |
Dec 31, 2013 | 102 | 15 | 17.24% |
Dec 31, 2012 | 87 | 26 | 42.62% |
Dec 31, 2011 | 61 | 26 | 74.29% |
Dec 31, 2010 | 35 | 16 | 84.21% |
Dec 31, 2009 | 19 | 15 | 375.00% |
Dec 31, 2008 | 4 | -10 | -71.43% |
Dec 31, 2007 | 14 | -8 | -36.36% |
Dec 31, 2006 | 22 | -27 | -55.10% |
Dec 31, 2005 | 49 | -22 | -30.99% |
Dec 31, 2004 | 71 | -11 | -13.41% |
Dec 31, 2003 | 82 | 7 | 9.33% |
Dec 31, 2002 | 75 | 7 | 10.29% |
Dec 31, 2001 | 68 | 24 | 54.55% |
Dec 31, 2000 | 44 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Encompass Health | 37,761 |
Henry Schein | 25,000 |
Solventum | 20,098 |
Chemed | 15,087 |
Bruker | 9,707 |
Bio-Rad Laboratories | 8,030 |
Bio-Rad Laboratories | 8,030 |
Qiagen | 5,967 |
EXAS News
- 4 days ago - Exact Sciences Awards Grants to 28 Organizations Focused on Increasing Colorectal Cancer Screening - Business Wire
- 14 days ago - Exact Sciences schedules second quarter 2024 earnings call - Business Wire
- 20 days ago - Geneoscopy Files Counterclaims Against Exact Sciences - Business Wire
- 6 weeks ago - Top 4 Health Care Stocks That Are Preparing To Pump This Month - Inhibrx Biosciences (NASDAQ:INBX) - Benzinga
- 7 weeks ago - Exact Sciences to Participate in June Investor Conferences - Business Wire
- 2 months ago - Exact Sciences Demonstrates Continued Leadership in Early Cancer Diagnosis and Improved Health Outcomes for Patients with Multiple Data Presentations at ASCO® - Business Wire
- 2 months ago - Court Dismisses Exact Sciences' ‘781 Patent Infringement Claim Against Geneoscopy - Business Wire
- 2 months ago - Exact Sciences Earns 2024 Great Place To Work® Certification™ - Business Wire